| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,925 |
18,783 |
$1.41M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,193 |
7,777 |
$806K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,725 |
1,708 |
$169K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,011 |
988 |
$91K |
| 90686 |
|
3,530 |
3,516 |
$51K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
554 |
530 |
$50K |
| 92551 |
|
3,617 |
3,512 |
$25K |
| 90832 |
Psychotherapy, 30 minutes with patient |
398 |
314 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,334 |
1,316 |
$14K |
| 96127 |
|
2,866 |
2,299 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
482 |
480 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
55 |
51 |
$5K |
| 90670 |
|
315 |
312 |
$4K |
| 0071A |
|
88 |
86 |
$4K |
| 0072A |
|
78 |
76 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
106 |
106 |
$3K |
| 90688 |
|
209 |
201 |
$3K |
| 90656 |
|
287 |
287 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
20 |
20 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
188 |
119 |
$2K |
| 90648 |
|
251 |
248 |
$2K |
| 90685 |
|
158 |
157 |
$2K |
| 0112A |
|
41 |
41 |
$2K |
| 90680 |
|
117 |
116 |
$2K |
| 97802 |
|
28 |
26 |
$1K |
| 90677 |
|
102 |
102 |
$1K |
| 90723 |
|
122 |
119 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
40 |
39 |
$1K |
| 99173 |
|
789 |
759 |
$1K |
| 90480 |
|
54 |
54 |
$1K |
| 90697 |
|
60 |
60 |
$995.07 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
13 |
$606.93 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$295.79 |
| 90672 |
|
14 |
14 |
$284.49 |
| 90633 |
|
12 |
12 |
$242.19 |
| 36416 |
|
51 |
50 |
$228.55 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$173.18 |
| 96161 |
|
104 |
103 |
$168.78 |
| 99051 |
|
41 |
41 |
$33.00 |
| 85018 |
|
13 |
13 |
$27.12 |
| 99072 |
|
13,853 |
12,763 |
$10.00 |